Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Neurological Sciences
Literature
1.
2.
Zhang HL, Zheng XY, Zhu J (2013) Th1/Th2/Th17/Treg cytokines in Guillain-Barré syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev 24:443–453CrossRef
3.
Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, van Doorn PA, Dourado ME, Hughes RAC, Islam B, Kusunoki S, Pardo CA, Reisin R, Sejvar JJ, Shahrizaila N, Soares C, Umapathi T, Wang Y, Yiu EM, Willison HJ, Jacobs BC (2019) Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol 15:671–683CrossRef
4.
Van Koningsveld R, Van Doorn PA, Schmitz PI, Ang CW, Van der Meché FG (2000) Mild forms of Guillain-Barré syndrome in an epidemiologic survey in the Netherlands. Neurology 54:620–625CrossRef
5.
Dimachkie MM, Barohn RJ (2013) Guillain-Barré syndrome and variants. Neurol Clin 31:491–510CrossRef
6.
Kuwabara S, Ogawara K, Misawa S, Koga M, Mori M, Hiraga A, Kanesaka T, Hattori T, Yuki N (2004) Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome? Neurology 63:529–533CrossRef
7.
Franciotta D, Gastaldi M, Benedetti L, Pesce G, Biagioli T, Lolli F, Costa G, Melis C, Andreetta F, Simoncini O, Giannotta C, Bazzigaluppi E, Fazio R, Bedin R, Ferraro D, Mariotto S, Ferrari S, Galloni E, De Riva V, Zardini E, Cortese A, Nobile-Orazio E (2017) Diagnostics of dysimmune peripheral neuropathies. Neurol Sci 38:243–247CrossRef
8.
Lardone RD, Alaniz ME, Irazoqui FJ, Nores GA (2006) Unusual presence of anti-GM1 IgG-antibodies in a healthy individual, and their possible involvement in the origin of disease-associated anti-GM1 antibodies. J Neuroimmunol 173:174–179CrossRef
9.
Grüter T, Ott A, Meyer W, Jarius S, Kinner M, Motte J, Pitarokoili K, Gold R, Komorowski L, Ayzenberg I (2020) Effects of IVIg treatment on autoantibody testing in neurological patients: marked reduction in sensitivity but reliable specificity. J Neurol 267:715–720
Metadata
Title
Axonal form of Guillain-Barré syndrome in a patient receiving oxaliplatin-based chemotherapy
Authors
Linpei Jia
Hongliang Zhang
Publication date
01-01-2021
Publisher
Springer International Publishing
Published in
Neurological Sciences / Issue 1/2021
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04560-w

Other articles of this Issue 1/2021

Neurological Sciences 1/2021 Go to the issue

Review Article

Reliability of the six-minute walk test in individuals with stroke: systematic review and meta-analysis

Brief Communication

Long-term persistence of NMDAR antibodies after encephalitis with de novo occurrence of demyelinating disorder

Letter to the Editor

MOG antibody syndrome presenting as aseptic meningitis: an evolving spectrum

COVID-19

New-onset refractory status epilepticus (NORSE) in post SARS-CoV-2 autoimmune encephalitis: a case report

COVID-19

Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19

Original Article

Optical coherence tomography in adult adrenoleukodystrophy: a cross-sectional and longitudinal study